Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial

CONCLUSIONS: This randomized triple-blind multi-centric clinical trial did not show any deleterious effects of ACEi/ARB medications in hypertensive COVID-19 patients.PMID:34265044 | DOI:10.1093/ajh/hpab111

Source: American Journal of Hypertension - July 15, 2021 Category: Cardiology Authors: Farhad Najmeddin Maedeh Solhjoo Haleh Ashraf Mohammadreza Salehi Fatemeh Rasooli Morteza Ghoghaei Abbas Soleimani Maryam Bahreini Source Type: research